The Investigator Databank is a global collaboration between Janssen, Lilly, Merck, Pfizer and Novartis (with more companies to come) to share investigator information that each company has on file with one another. Investigator Databank aims to reduce administrative burden for investigators and to increase visibility of qualified investigators to research sponsors.
FSR partners with the Investigator Databank!
The Investigator Databank is a global collaboration between Janssen, Lilly, Merck, Pfizer and Novartis (with more companies to come) to share investigator information that each company has on file with one another. Investigator Databank aims to reduce administrative burden for investigators and to increase visibility of qualified investigators to research sponsors. Learn more.
December 8, 2015
Categories
Recent Posts
- FSR Doubles Investment in Cardiac Sarcoidosis Research with $200,000 in Grants to Advance Diagnostic and Treatment Breakthroughs
- FSR receives confirmation from the Department of Labor ensuring patient access to FMLA for participation in clinical trials
- Nearly 350 Patients Participate in the Foundation for Sarcoidosis Research Externally Led Patient-Focused Drug Development Meeting with the FDA
- 12 Years of Sarcoidosis Advocacy
- Sarcoidosis…and the Sound of Silence